Cargando…
In vitro characterization of cells derived from chordoma cell line U-CH1 following treatment with X-rays, heavy ions and chemotherapeutic drugs
BACKGROUND: Chordoma, a rare cancer, is usually treated with surgery and/or radiation. However, very limited characterizations of chordoma cells are available due to a minimal availability (only two lines validated by now) and the extremely long doubling time. In order to overcome this situation, we...
Autores principales: | Kato, Takamitsu A, Tsuda, Akihisa, Uesaka, Mitsuru, Fujimori, Akira, Kamada, Tadashi, Tsujii, Hirohiko, Okayasu, Ryuichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182904/ https://www.ncbi.nlm.nih.gov/pubmed/21914223 http://dx.doi.org/10.1186/1748-717X-6-116 |
Ejemplares similares
-
Comparison of human chordoma cell-kill for 290 MeV/n carbon ions versus 70 MeV protons in vitro
por: Fujisawa, Hiroshi, et al.
Publicado: (2013) -
VE-821, an ATR inhibitor, causes radiosensitization in human tumor cells irradiated with high LET radiation
por: Fujisawa, Hiroshi, et al.
Publicado: (2015) -
Chordoma‐derived cell line U‐CH1‐N recapitulates the biological properties of notochordal nucleus pulposus cells
por: Fujita, Nobuyuki, et al.
Publicado: (2016) -
A Review of Update Clinical Results of Carbon Ion Radiotherapy
por: Tsujii, Hirohiko, et al.
Publicado: (2012) -
Nontoxic concentration of DNA‐PK inhibitor NU7441 radio‐sensitizes lung tumor cells with little effect on double strand break repair
por: Sunada, Shigeaki, et al.
Publicado: (2016)